DrugJul 26, 2023
SterRx Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single recall — FDA D-0931-2023
Lack of Assurance of Sterility
Class IIFDA: TerminatedSterRx, LLC
Latest records
Latest recalls — page 273
The newest recall records with useful source details are listed here.
VehicleJul 21, 2023
Ford instrument cluster/panel recall — NHTSA campaign 23V506000
Ford Motor Company (Ford) is recalling certain 2023 Escape, Super Duty F-250, Super Duty F-350, Super Duty F-450, and Super Duty F-550 vehicles equipped with a digital instrument panel…
instrument cluster/panelFord Motor Company
VehicleJul 21, 2023
F-150 electrical recall — NHTSA campaign 23V509000
Ford Motor Company (Ford) is recalling certain 2021-2023 F-150 vehicles equipped with a single exhaust system. Contact with the rear axle housing may damage the wiring harness, causing the…
electricalFord Motor Company
DrugJul 19, 2023
Tenn South Distillery LLC dba Big Machine Big Machine Distillery Hand Sanitizer Non-Sterile recall — FDA D-0915-2023
CGMP Deviation: impurities exceed allowable limits.
Class IIFDA: OngoingTenn South Distillery LLC dba Big Machine Distillery
DrugJul 19, 2023
SUNMARK EYE DROPS ORIGINAL FORMULA Original Eye Drops recall — FDA D-0897-2023
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc.
DrugJul 19, 2023
Global Pharma Healthcare Private Delsam Pharma's ARTIFICIAL TEARS recall — FDA D-0922-2023
CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be…
Class IIFDA: OngoingGlobal Pharma Healthcare Private Limited
DrugJul 19, 2023
Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials recall — FDA D-0917-2023
Presence of Particulate Matter: Particulate matter identified as fiber.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugJul 19, 2023
Global Pharma Healthcare Private Artificial Tears recall — FDA D-0920-2023
CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be…
Class IIFDA: OngoingGlobal Pharma Healthcare Private Limited
DrugJul 19, 2023
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g recall — FDA D-0938-2023
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Class IFDA: TerminatedCipla USA, Inc.
DrugJul 19, 2023
Global Pharma Healthcare Private Delsam Pharma's ARTIFICIAL TEARS recall — FDA D-0921-2023
Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Class IFDA: OngoingGlobal Pharma Healthcare Private Limited
DrugJul 19, 2023
Bivalirudin for Injection 250 mg, 10 Single-Dose Vials recall — FDA D-0918-2023
Presence of Particulate Matter: Particulate matter identified as fiber.
Class IIFDA: TerminatedAccord Healthcare, Inc.
DrugJul 19, 2023
Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles recall — FDA D-0899-2023
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
Class IIIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugJul 19, 2023
Global Pharma Healthcare Private Artificial Tears recall — FDA D-0919-2023
Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Class IFDA: OngoingGlobal Pharma Healthcare Private Limited
DrugJul 19, 2023
Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle recall — FDA D-0914-2023
Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugJul 19, 2023
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles recall — FDA D-0913-2023
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Class IIFDA: TerminatedTeva Pharmaceuticals USA Inc.
DrugJul 19, 2023
EQUATE EYE DROPS DRY EYE RELIEF Dry Eye Relief Lubricant Eye Drops recall — FDA D-0898-2023
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc.
VehicleJul 14, 2023
Tesla front recall — NHTSA campaign 23V488000
Tesla, Inc. (Tesla) is recalling certain 2021-2023 Model S and Model X vehicles. The front-row seat belts may not be connected properly to the pretensioner anchors, which can cause the seat…
frontTesla, Inc.
VehicleJul 14, 2023
Tesla camera recall — NHTSA campaign 23V489000
Tesla, Inc. (Tesla) is recalling certain 2023 Model S, Model X, and Model Y vehicles. The forward-facing camera may be misaligned, causing some of the active safety features such as…
cameraTesla, Inc.
DrugJul 12, 2023
Tizanidine Tablets, USP, 4 mg, 100 Tablets recall — FDA D-0892-2023
Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.
Class IIFDA: TerminatedAmerisource Health Services LLC
DrugJul 12, 2023
Tizanidine Hydrochloride Tablet 4mg recall — FDA D-0894-2023
Failed Stability Specifications
Class IIFDA: OngoingPreferred Pharmaceuticals, Inc.
DrugJul 12, 2023
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle recall — FDA D-0895-2023
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Class IIFDA: TerminatedStrides Pharma Inc.
VehicleJul 12, 2023
Toyota Motor Engineering & Manufacturing column recall — NHTSA campaign 23V480000
Toyota Motor Engineering & Manufacturing (Toyota) is recalling certain 2023 Corolla, Corolla Cross, Corolla Cross Hybrid, Highlander, Highlander Hybrid, Tacoma, 2023 Lexus RX350, RX350…
columnToyota Motor Engineering & Manufacturing
VehicleJul 11, 2023
Toyota RAV4 valve recall — NHTSA campaign 23V485000
Gulf States Toyota, Inc. (GST) is recalling certain 2023 Toyota RAV4 vehicles equipped with 17" black alloy accessory wheels. During installation of the alloy wheels, the tire valve stem…
valveGulf States Toyota, Inc.
DrugJul 5, 2023
The Harvard Drug Group Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count recall — FDA D-0878-2023
Packaging defect: blister packaging inadequately sealed.
Class IIFDA: TerminatedThe Harvard Drug Group
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories